Clinical trials
Recruiting Polycythemia Vera trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeBetter Med Inc | 1 |
| Chengdu Zenitar Biomedical Technology Co., Ltd | 1 |
| Duan Minghui | 1 |
| Hangzhou GluBio Pharmaceutical Co., Ltd. | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 1 |
| Zhenya Hong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polycythemia Vera | 7 |
| Thrombocythemia, Essential | 2 |
| Leukemia, Myeloid, Acute | 1 |
| Myelodysplastic Syndromes | 1 |
| Primary Myelofibrosis | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.